Olema Pharmaceuticals Q2 Net Income USD -63.2 Million
OLMA•Q2 operating results
Aug. 10 (Reuters) - Olema Pharmaceuticals Q2 income from operations USD -67.179 million.
- Q2 operating expenses USD 67.179 million
Related News
Atkore Pres. Safety & Infrastructure Mark F. Lamps sells 300 shares for $28,125
ATKR•
Community West Bancshares Q2 FY26 net income drops 65.59% to $2.7 million; net interest margin widens 26 basis points to 4.56%
CWBC•
Sable Offshore net loss narrows to $64.22 million in Q2 FY26; revenue turns to $137.13 million
SOC•
